Can You Stop These Medications After a Year of Vertigo-Free Treatment?
Yes, you can consider discontinuing both medications after a year of symptom-free treatment, but the amitriptyline (Eliwel) requires a very slow, gradual taper while betahistine (Zapis) can typically be stopped more directly.
Understanding Your Medications
You're taking two different types of medications:
- Eliwel (amitriptyline) 0.25 mg - This is a tricyclic antidepressant used off-label for vertigo prevention
- Zapis (betahistine) - A histamine analog specifically for vestibular vertigo
Stopping Betahistine (Zapis)
Betahistine can generally be discontinued without a prolonged taper. Research shows that betahistine's beneficial effects on vertigo persist for at least 2 months after treatment cessation, suggesting it facilitates lasting vestibular compensation rather than just suppressing symptoms 1. Since you've been symptom-free for over a year, your vestibular system has likely compensated fully.
Approach for Zapis:
- Can be stopped directly or reduced over 1-2 weeks
- Monitor for return of vertigo symptoms for 2-4 weeks after stopping
- Rare adverse effects from discontinuation (primarily mild neuropsychiatric symptoms in susceptible individuals) 2
Tapering Amitriptyline (Eliwel) - This Requires More Caution
Your dose of 0.25 mg is extremely low, but amitriptyline still requires gradual tapering to avoid withdrawal symptoms. After a year of daily use, physical dependence can develop even at low doses 3.
Withdrawal Symptoms to Watch For
Amitriptyline withdrawal can cause 3:
- Nausea, headache, malaise
- Irritability, restlessness
- Sleep disturbance and vivid dreams
- Anticholinergic rebound: sweating, urinary urgency 4
Recommended Tapering Strategy
For your 0.25 mg dose (half of a 0.5 mg tablet), use hyperbolic tapering over 2-3 months:
- Weeks 1-4: Reduce to approximately 0.22 mg (reduce by ~10%)
- Weeks 5-8: Reduce to approximately 0.20 mg
- Weeks 9-12: Reduce to approximately 0.15 mg
- Continue reducing by 5-10% of the current dose every 2-4 weeks
The principle: Each reduction should be 5-10% of your current dose, not your starting dose 5. This creates smaller absolute reductions as you approach zero, matching how the drug affects your brain receptors 6.
Practical Implementation Challenges
At your very low dose, cutting tablets becomes impractical. Consider:
- Liquid formulation from a compounding pharmacy to enable precise micro-doses
- Dissolving tablets in water and measuring portions
- Discuss with your pharmacist about compounding options for doses below 0.1 mg
Monitoring During the Taper
- Check in with your provider every 2-4 weeks 5
- If withdrawal symptoms emerge: pause the taper at your current dose for 2-4 weeks until symptoms resolve 5
- If symptoms are intolerable: return to the previous dose temporarily 5
- Continue monitoring for 2-4 weeks after complete discontinuation 5
Important Caveats
Do not stop abruptly. While some guidelines suggest medications with long half-lives can be stopped without tapering 7, amitriptyline has documented withdrawal syndromes requiring gradual reduction 3, 8.
Distinguish withdrawal from vertigo relapse:
- Withdrawal symptoms typically appear within days of dose reduction and improve with time
- Vertigo relapse would present as your original spinning sensations returning
- If true vertigo returns, this represents disease recurrence, not withdrawal
Benzodiazepines are not recommended for vertigo treatment 9, so if your provider suggests switching to those during tapering, decline this approach.
Timeline Expectations
- Betahistine: Can stop within 1-2 weeks
- Amitriptyline: Plan for 2-4 months minimum for safe tapering from 0.25 mg
- Total discontinuation timeline: 3-5 months for both medications
When to Seek Help Immediately
Contact your provider if you experience:
- Severe or intolerable withdrawal symptoms
- Return of vertigo attacks
- New psychiatric symptoms (anxiety, depression, suicidal thoughts)
- Seizures or severe confusion (rare but serious) 3
Work with your prescribing provider to develop this tapering plan through shared decision-making 5. Your year of symptom-free treatment suggests successful vestibular compensation, making discontinuation reasonable, but the process must be gradual and monitored.